Drug Discovery Today
FEBRUARY 3, 2021
February 4th is World Cancer Day. As Covid continues to re-shape our lives it is important to keep awareness about men’s health high. Recent news about Greg Rutherford’s detection of a cyst is a reminder that it is important for men to get regular check-ups. Testicular cancer is one of the most common forms of cancer in males and it affects around 2,300 men in the UK each year.
Drug Patent Watch
OCTOBER 4, 2021
This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference. I discuss: Identifying generic entry opportunities at the earliest stages Discovering opportunities that avoid litigation…. The post Generic Portfolio Management, Partnering with Brands, and Staying Competitive appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
DrugBaron
FEBRUARY 16, 2021
Monoclonal antibodies are now well-established as a mainstay of the therapeutic armoury. More than a hundred antibodies have now been approved as drugs, making up around a third of all approvals over the last three years. This reflects a number of inherent advantages of antibodies over “conventional” small-molecule drugs: their inherent specificity allows off-target toxicities to be eliminated; their long-life makes them suitable for infrequent dosing, in some cases as little as twice in a ye
Eye on FDA
AUGUST 4, 2021
As more drugs are being approved, is FDA getting less advice than in the past? FDA maintains a vast network of outside advisors to provide input and counsel to the agency related to decisions on policy as well as product approvals. There are 31 advisory committees on matters ranging from food to medical devices to pediatric care. Within those focused on human drugs , there are 17 committees organized under therapeutic categories (Arthritis, Cardiovascular and Renal, Gastrointestinal, e.g.).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Channels
NOVEMBER 2, 2021
Open enrollment is under way for the 2022 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design. For 2022: 98% of stand-alone Medicare Part D prescription drug plans (PDP) will have a preferred network. 66% of Medicare Advantage prescription drug (MA-PD) plans will have a preferred network.
Drug Discovery Today
MARCH 26, 2021
Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug Discovery Today
APRIL 20, 2021
Please join us at the Zoom launch event for Elsevier’s new journal: “Artificial Intelligence in the Life Sciences” Wednesday May 5th 2021 at 3:00pm UK time.
Drug Discovery Today
MARCH 26, 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) has registered Virolens, which is now the fastest COVID-19 screening device in the country. Instant Covid Tests London’s (ICTL) test centre is based at The Brewery events space in the City of London, neighbouring thousands of workplaces.
Drug Discovery Today
MAY 25, 2021
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service
Drug Discovery Today
DECEMBER 21, 2021
Lab Innovations, the UK’s largest trade exhibition for the laboratory industry, returned to the NEC, Birmingham, on November 3 and 4, 2021 and brought the laboratory community together for the first time after almost two years apart. With 3,117 visitors, the show gave the industry’s leading professionals and companies the chance to meet face-to-face, network and discover the latest innovations.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Discovery Today
DECEMBER 3, 2021
Alderley Park, Cheshire – One of the UK’s leading infectious disease biotech companies has announced a breakthrough in laboratory trials of a new drug to treat COVID-19 and new variants of the disease, such as the Omicron variant.
Drug Discovery Today
NOVEMBER 9, 2021
Innovate UK grant awarded for the development of quantum computing in cancer treatment
Drug Discovery Today
OCTOBER 28, 2021
Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million (circa £30 million) investment round. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms.
Drug Discovery Today
SEPTEMBER 22, 2021
AstraZeneca scientists, based in Cambridge UK, have analysed over 18,000 phenotypes in combination with whole exome sequencing data from nearly 300,000 UK Biobank research participants.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Discovery Today
SEPTEMBER 16, 2021
Demand for Touchlight’s synthetic DNA vector has grown rapidly since last year.dbDNA™ is driving biomedical innovations such as DNA and mRNA vaccines, synthetic DNA-based neutralising antibody therapies, and more.Touchlight’s synthetic DNA vector is revolutionising genetic medicine manufacture by offering a superior alternative to traditional plasmid DNA.
Drug Discovery Today
AUGUST 23, 2021
Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland, has topped out.
Drug Discovery Today
AUGUST 20, 2021
• ELRIG Drug Discovery 2021, ACC Liverpool, UK, 19–20 October• Face-to-face event aims to re-connect, re-invent, and re-imagine drug discovery• SLAS’s Innovation AveNEW promotes start-ups by awarding free-of-charge exhibition space and access to a network of potential business partners
Drug Discovery Today
AUGUST 18, 2021
A new study, produced in partnership between the Royal Veterinary College (RVC), the Wellcome Sanger Institute, Imperial College and the Vector Borne and Neglected Tropical Disease Control Division of the Ministry of Health, Uganda, has been published in Nature Communications. This research paves the way for a more effective genomic surveillance of schistosomiasis, a major human parasite.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Discovery Today
AUGUST 18, 2021
Wallops Flight Facility, VA. August 10, 2021 - An 18-year-old high school graduate has developed an elegant new way to gauge the liver health of astronauts—and it could someday help solve an enduring medical mystery in space.
Drug Discovery Today
AUGUST 16, 2021
Manchester, UK, August 11, 2021: Monument Therapeutics, a stratified medicine company, today announced Monument Therapeutics the appointment of Dr Julian Gilbert to its Board as a Non-Executive Director. Monument recently raised £2.625 million in seed funding and applies a novel drug development strategy, leveraging digital assessments of cognition to match patients with new pharmaceutical treatments.
Drug Discovery Today
AUGUST 3, 2021
New role for Dr Kath Mackay reflects ambitions of Bruntwood SciTech and growth of the UK’s life sciences sector
Drug Discovery Today
JULY 18, 2021
~ UK’s biggest trade show for the laboratory industry returns for 2021 ~
Drug Discovery Today
JULY 8, 2021
The topic of this month’s newsletter from Drug Discovery Today is “Cardiovascular Drugs”.
Drug Discovery Today
JULY 7, 2021
Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction
Drug Discovery Today
MAY 11, 2021
Oslo, Norway, May 10, 2021 – Lytix Biopharma AS, a Norwegian clinical-stage immunoncology therapeutic company developing oncolytic molecule therapies to treat cancer, today announces that promising full data results from a phase I study of its lead candidate LTX-315 were published in Clinical Cancer Research, a peer-reviewed journal of the American Association for Cancer Research.
Drug Discovery Today
APRIL 22, 2021
A woman who has transformed commercialisation of medical research at the University of Edinburgh has been named Knowledge Exchange Hero 2021 in the Scottish Knowledge Exchange Awards.
Drug Discovery Today
APRIL 15, 2021
Company’s technologies and drug-hunting expertise now responsible for world’s first and second AI-designed drugs to enter Phase I testing
Drug Discovery Today
APRIL 15, 2021
First subjects dosed with AKS-452, COVID-19 vaccine candidate in the Netherlands trial the vaccine is shelf-stable for 4 months at 25 degrees Celsius (77° Fahrenheit).
Drug Discovery Today
APRIL 8, 2021
Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, announced that it would be working with Ataxia UK and FARA to develop novel treatments for Friedreich's ataxia - a rare neurodegenerative condition that causes issues with balance, speech and coordination.
Drug Discovery Today
APRIL 7, 2021
An £8.7 million, five-year research collaboration led by the University of Edinburgh and FUJIFILM Diosynth Biotechnologies UK (FDB) will develop more cost-effective ways to make modern antibody-based medicines.
Drug Discovery Today
APRIL 2, 2021
A palliative care doctor has suggested that studying Shakespeare’s plays could help medical students connect more closely with their patients. Writing in the Journal of the Royal Society of Medicine Dr David Jeffrey, of the Department of Palliative Medicine at the University of Edinburgh, investigates how the playwright’s empathic approach - the ability to understand and share the feelings of another - can enhance the patient-doctor relationship.
Drug Discovery Today
MARCH 31, 2021
Global not-for-profit launches a Data Governance Community of Interest to help companies improve data sharing infrastructure to accelerate R&D innovation
Drug Discovery Today
MARCH 9, 2021
New service supports UK government test-to-release scheme for day 2 testing.
Expert insights. Personalized for you.
201 
Let's personalize your content